OPR - Delayed Quote • USD CLDX Aug 2024 50.000 call (CLDX240816C00050000) Follow 0.8000 -1.0700 (-57.22%) At close: April 17 at 1:24 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for CLDX240816C00050000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: CLDX Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria Down -14.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Celldex (CLDX) All You Need to Know About Celldex (CLDX) Rating Upgrade to Buy Down -17.39% in 4 Weeks, Here's Why You Should You Buy the Dip in Celldex (CLDX) Does Celldex (CLDX) Have the Potential to Rally 71.82% as Wall Street Analysts Expect? Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock Celldex (CLDX) Upgraded to Buy: What Does It Mean for the Stock? Wall Street Analysts Predict a 26.53% Upside in Celldex (CLDX): Here's What You Should Know Celldex Therapeutics Announces Proposed Public Offering of Common Stock
